Nothenberg et al., 1991 - Google Patents
Adducts of nitroimidazole derivatives with rhodium (II) carboxylates: Syntheses, characterization, and evaluation of antichagasic activitiesNothenberg et al., 1991
- Document ID
- 2632327452995054648
- Author
- Nothenberg M
- Takeda G
- Najjar R
- Publication year
- Publication venue
- Journal of inorganic biochemistry
External Links
Snippet
Adducts of several rhodium (II) carboxylates with two antiparasitic nitroimidazole ligands were prepared and characterized by elemental microanalysis, thermogravimetry, spectrophotometry (IR, UV, and visible), and proton magnetic resonance. Results of …
- -1 rhodium (II) carboxylates 0 title abstract description 13
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
- C07F15/0073—Rhodium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gümüş et al. | Synthesis, cytotoxic activity on MCF-7 cell line and mutagenic activity of platinum (II) complexes with 2-substituted benzimidazole ligands | |
Nothenberg et al. | Adducts of nitroimidazole derivatives with rhodium (II) carboxylates: Syntheses, characterization, and evaluation of antichagasic activities | |
CN101948488B (en) | Ruthenium-selenium coordination compound and application thereof in preparing fluorescent probe and antineoplastic medicine | |
US6969765B2 (en) | Photosensitizer and method for production thereof | |
Das et al. | Are Zn (II) pincer complexes efficient apoptosis inducers? a deep insight into their activity against A549 lung cancer cells | |
CN104592091B (en) | A kind of compound and its application containing heteroauxin core texture | |
EP0575890B1 (en) | Fumaric acid salts of quinoline derivatives to overcome MDR in cancer treatment | |
US11192882B2 (en) | Crystal form of small molecule immune compound, preparation method thereof and pharmaceutical composition containing the same | |
Maeda et al. | Synthesis of seleno-and thioguanine-platinum (II) complexes and their antitumor activity in mice | |
RU2429242C2 (en) | Using tetranitrosyl complex of iron with thiophenol as anti-tumour medicinal agent | |
US11981626B1 (en) | Compound embodiments for hydrogen sulfide production and methods of making and using the same | |
WO2008147243A1 (en) | Binuclear nirtosyl-iron complexes with benzo-trans-heterocyclic derivatives and a method for the production thereof | |
RU2476424C1 (en) | N-(3-chloro-4-propyloxyphenyl)-3,5-dichlorosalicylamide having anthelmintic activity | |
CN104402894B (en) | 3-(1-alkoxyl oxygen alkyl ethyl) metal complex and its preparation method and application of chlorin e 6 analog | |
US11999755B1 (en) | Effective anticancer drug candidate of dinuclear palladium (II) bis-dihydrozone malonyl complex | |
US12054451B1 (en) | Water soluble platinum (II) amino acid schiff base as an antitumor drug | |
RU2070201C1 (en) | Bis(1-vinylimidazole)zinc diacetate as carbon oxide antidote | |
RU2783659C1 (en) | 2-[5-(4-methoxy)-3-phenyl-5,6-dihydro-4h-[1,2,4,5]tetrazin-1-yl]-benzothiazoles with antiviral activity against coxsackie b3 viruses | |
Mazzo et al. | Celiprolol hydrochloride | |
EP3967702B1 (en) | Crystallization of smac mimic used as iap inhibitor and preparation method thereof | |
RU2441872C2 (en) | Binuclear nitrosyl iron complexes with benzazeheterocyclic derivatives, ways of its production | |
CN109824623A (en) | A kind of list Demethoxycurcumin azole derivatives and its preparation method and application | |
WO2018067842A1 (en) | Aziridinyl and amino dimeric naphthoquinone compounds and use for acute myeloid leukemia | |
SU668275A1 (en) | Derivatives of 5-oxyalkyl-5,10-dihydropyridazino /3,4/ quinoxaline displaying antitumor activity | |
CN101230015A (en) | Substituted cinnamic acid derivatives containing amine substituent group and expression purification cytotoxicity thereof |